|
1
|
Bhatt JR and Finelli A: Landmarks in the
diagnosis and treatment of renal cell carcinoma. Nat Rev Urol.
11:517–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kovacs G, Akhtar M, Beckwith BJ, Bugert P,
Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros
LJ, et al: The Heidelberg classification of renal cell tumours. J
Pathol. 183:131–133. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Campbell D, Walker R, Mathew T and Craig
J: Commentary on ‘Influence of industry on renal guideline
development’. Clin J Am Soc Nephrol. 2:2112007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Papachristou DJ, Korpetinou A,
Giannopoulou E, Antonacopoulou AG, Papadaki H, Grivas P, Scopa CD
and Kalofonos HP: Expression of the ribonucleases Drosha, Dicer,
and Ago2 in colorectal carcinomas. Virchows Arch. 459:431–440.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mockenhaupt S, Schurmann N and Grimm D:
When cellular networks run out of control: Global dysregulation of
the RNAi machinery in human pathology and therapy. Prog Mol Biol
Transl Sci. 102:165–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim S, Song ML, Min H, Hwang I, Baek SK,
Kwon TK and Park JW: miRNA biogenesis-associated RNase III
nucleases Drosha and Dicer are upregulated in colorectal
adenocarcinoma. Oncol Lett. 14:4379–4383. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hata A and Kashima R: Dysregulation of
microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol.
51:121–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tchernitsa O, Kasajima A, Schäfer R, Kuban
RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP
and Röcken C: Systematic evaluation of the miRNA-ome and its
downstream effects on mRNA expression identifies gastric cancer
progression. J Pathol. 222:310–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaikhibrahim Z, Lindstrot A, Ochsenfahrt
J, Fuchs K and Wernert N: Epigenetics-related genes in prostate
cancer: Expression profile in prostate cancer tissues,
androgen-sensitive and -insensitive cell lines. Int J Mol Med.
31:21–25. 2013.PubMed/NCBI
|
|
12
|
Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai
Q, Ni D, Chen W, Zhang P, Song E, et al: Dicer is down-regulated in
clear cell renal cell carcinoma and in vitro Dicer knockdown
enhances malignant phenotype transformation. Urol Oncol.
32:46.e9–e17. 2014. View Article : Google Scholar
|
|
13
|
Fan Y, Li H, Ma X, Gao Y, Bao X, Du Q, Ma
M, Liu K, Yao Y, Huang Q, et al: Dicer suppresses the malignant
phenotype in VHL-deficient clear cell renal cell carcinoma by
inhibiting HIF-2α. Oncotarget. 7:18280–18294. 2016.PubMed/NCBI
|
|
14
|
Lin J, Horikawa Y, Tamboli P, Clague J,
Wood CG and Wu X: Genetic variations in microRNA-related genes are
associated with survival and recurrence in patients with renal cell
carcinoma. Carcinogenesis. 31:1805–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A: AJCC cancer staging handbook: From the AJCC
cancer staging manual. Springer; New York: 2010
|
|
17
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gurtner A, Falcone E, Garibaldi F and
Piaggio G: Dysregulation of microRNA biogenesis in cancer: The
impact of mutant p53 on Drosha complex activity. J Exp Clin Cancer
Res. 35:452016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Li WF, Wu X, Zhang HC, Chen L,
Zhang PY, Liu LY, Ma D, Chen T, Zhou L, et al: Dicer regulates
non-homologous end joining and is associated with chemosensitivity
in colon cancer patients. Carcinogenesis. 38:873–882. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
To SKY, Mak ASC, Eva Fung YM, Che CM, Li
SS, Deng W, Ru B, Zhang J and Wong AST: β-catenin downregulates
Dicer to promote ovarian cancer metastasis. Oncogene. 36:5927–5938.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Z, Wang L, Wang C, Ju X, Wang M, Chen
K, Loro E, Li Z, Zhang Y, Wu K, et al: Cyclin D1 induction of Dicer
governs microRNA processing and expression in breast cancer. Nat
Commun. 4:28122013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diaz-Garcia CV, Agudo-López A, Pérez C,
López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A,
Martínez-Villanueva M, Iglesias L, García-Carbonero R, et al:
DICER1, DROSHA and miRNAs in patients with non-small cell lung
cancer: Implications for outcomes and histologic classification.
Carcinogenesis. 34:1031–1038. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim B, Lee JH, Park JW, Kwon TK, Baek SK,
Hwang I and Kim S: An essential microRNA maturing microprocessor
complex component DGCR8 is up-regulated in colorectal carcinomas.
Clin Exp Med. 14:331–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Passon N, Gerometta A, Puppin C, Lavarone
E, Puglisi F, Tell G, Di Loreto C and Damante G: Expression of
Dicer and Drosha in triple-negative breast cancer. J Clin Pathol.
65:320–326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim J, Park WJ, Jeong KJ, Kang SH, Kwon
SY, Kim S and Park JW: Racial differences in expression levels of
miRNA machinery-related genes, Dicer, Drosha, DGCR8, and AGO2, in
Asian Korean papillary thyroid carcinoma and comparative validation
using the cancer genome atlas. Int J Genomics. 2017:57897692017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vaksman O, Hetland TE, Trope' CG, Reich R
and Davidson B: Argonaute, Dicer, and Drosha are up-regulated along
tumor progression in serous ovarian carcinoma. Hum Pathol.
43:2062–2069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY,
Diccianni MB, London WB, Chang CH and Yu AL: microRNA signature and
expression of Dicer and Drosha can predict prognosis and delineate
risk groups in neuroblastoma. Cancer Res. 70:7841–7850. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stratmann J, Wang CJ, Gnosa S, Wallin A,
Hinselwood D, Sun XF and Zhang H: Dicer and miRNA in relation to
clinicopathological variables in colorectal cancer patients. BMC
Cancer. 11:3452011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shu GS, Yang ZL and Liu DC:
Immunohistochemical study of Dicer and Drosha expression in the
benign and malignant lesions of gallbladder and their
clinicopathological significances. Pathol Res Pract. 208:392–397.
2012. View Article : Google Scholar : PubMed/NCBI
|
